A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism

被引:6
|
作者
Apaolaza, Inigo [1 ,2 ,3 ]
San Jose-Eneriz, Edurne [4 ,5 ,6 ]
Valcarcel, Luis V. [1 ,4 ,5 ]
Agirre, Xabier [4 ,5 ,6 ]
Prosper, Felipe [4 ,5 ,6 ,7 ]
Planes, Francisco J. [1 ,2 ,3 ]
机构
[1] Univ Navarra, Tecnun Escuela Ingn, San Sebastian, Spain
[2] Univ Navarra, Ctr Ingn Biomed, Pamplona, Spain
[3] Univ Navarra, DATAI Inst Ciencia Datos & Inteligencia Artificia, Pamplona, Spain
[4] Univ Navarra, CIMA Ctr Invest Med Aplicada, Pamplona, Spain
[5] IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain
[6] CIBERONC Ctr Invest Biomed Red Canc, Pamplona, Spain
[7] Clin Univ Navarra, Pamplona, Spain
关键词
CELLS; REQUIREMENTS;
D O I
10.1371/journal.pcbi.1009395
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies. Author summary Metabolic reprogramming is one of the hallmarks of tumor cells. Synthetic lethality (SL) is a promising approach to exploit these metabolic alterations and elucidate cancer-specific genetic dependences. However, current SL approaches do not systematically consider tumor microenvironment, which is particularly important in cancer metabolism in order to generalize identified genetic dependences. In this article, we directly address this issue and propose a more general approach to SL that integrates both genetic and environmental context of tumor cells. Our definition can help to contextualize genetic dependencies in different environmental scenarios, but it could also reveal nutrient dependencies according to the genetic context. We also provide a computational pipeline to identify this new family of synthetic lethals in genome-scale metabolic networks. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of cancer cell lines, elucidating cholesterol and myo-Inositol depletion as potential vulnerabilities in different malignancies.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Network-based prediction approach for cancer-specific driver missense mutations using a graph neural network
    Narumi Hatano
    Mayumi Kamada
    Ryosuke Kojima
    Yasushi Okuno
    BMC Bioinformatics, 24
  • [22] Network-based prediction approach for cancer-specific driver missense mutations using a graph neural network
    Hatano, Narumi
    Kamada, Mayumi
    Kojima, Ryosuke
    Okuno, Yasushi
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [23] Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies
    Bajpai, Richa
    Shanmugam, Mala
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 338 - 344
  • [24] Network-based prediction of anti-cancer drug combinations
    Jiang, Jue
    Wei, Xuxu
    Lu, Yukang
    Li, Simin
    Xu, Xue
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [25] Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
    Salvatore Benfatto
    Özdemirhan Serçin
    Francesca R. Dejure
    Amir Abdollahi
    Frank T. Zenke
    Balca R. Mardin
    Molecular Cancer, 20
  • [26] Benchmarking machine learning methods for synthetic lethality prediction in cancer
    Feng, Yimiao
    Long, Yahui
    Wang, He
    Ouyang, Yang
    Li, Quan
    Wu, Min
    Zheng, Jie
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [27] Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
    Benfatto, Salvatore
    Sercin, Ozdemirhan
    Dejure, Francesca R.
    Abdollahi, Amir
    Zenke, Frank T.
    Mardin, Balca R.
    MOLECULAR CANCER, 2021, 20 (01)
  • [28] Biomarker prediction in autism spectrum disorder using a network-based approach
    Rastegari, Maryam
    Salehi, Najmeh
    Zare-Mirakabad, Fatemeh
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [29] Neural Network-Based Aircraft Conflict Prediction in Final Approach Maneuvers
    Casado, Rafael
    Bermudez, Aurelio
    ELECTRONICS, 2020, 9 (10) : 1 - 18
  • [30] Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
    Emig, Dorothea
    Ivliev, Alexander
    Pustovalova, Olga
    Lancashire, Lee
    Bureeva, Svetlana
    Nikolsky, Yuri
    Bessarabova, Marina
    PLOS ONE, 2013, 8 (04):